A challenge in public health: the etiological treatment of chronic Chagas' disease

Authors

  • Renata de Abreu Pedra FCMS/PUC-SP
  • Raquel Aparecida de Oliveira FCMS/PUC-SP
  • Carolina Guilherme Prestes Beyrodt FCMS/PUC-SP
  • Hudson Hübner França FCMS/PUC-SP

Keywords:

Chagas' disease, chronic disease, Chagas cardiomyopathy, treatment.

Abstract

ABSTRACT Chagas' disease is a neglected disease. Major pharmaceutical companies are not interested in researching new drugs which are not commonly sold and reach only a small population of economically excluded people. In Brazil, only Benzonidazol is available for treatment. Whereas for the acute disease there is no doubt as to its effectiveness, for the chronic phase opinions are not unanimous. The aim of this study was to review the literature on the subject. This issue is relevant due to its endemic profile in Latin America and the lack of review articles on the subject. Despite the fact that the parasite is not completely eradicated through treatment, it is believed that treatment during the chronic infection can prevent the development of severe cardiomyopathy.

Downloads

Download data is not yet available.

Author Biographies

Renata de Abreu Pedra, FCMS/PUC-SP

Acadêmica do Curso de Medicina da FCMS/PUC-SP

Raquel Aparecida de Oliveira, FCMS/PUC-SP

Acadêmica do Curso de Medicina da FCMS/PUC-SP

Carolina Guilherme Prestes Beyrodt, FCMS/PUC-SP

Professora do Depto. de Morfologia e Patologia FCMS/PUC-SP

Hudson Hübner França, FCMS/PUC-SP

Professor do Depto. de Medicina FCMS/PUCSP

Downloads

Published

2011-06-27

How to Cite

1.
Pedra R de A, de Oliveira RA, Prestes Beyrodt CG, França HH. A challenge in public health: the etiological treatment of chronic Chagas’ disease. Rev. Fac. Ciênc. Méd. Sorocaba [Internet]. 2011Jun.27 [cited 2024Dec.22];13(2):5-9. Available from: https://revistas.pucsp.br/index.php/RFCMS/article/view/3404

Issue

Vol. 13 No. 2 (2011)

Section

Review

License

Os autores no momento da submissão transferem os direitos autorais, assim, os manuscritos publicados passam a ser propriedade da revista.

O conteúdo do periódico está licenciado sob uma Licença Creative Commons 4.0, esta licença permite o livre acesso imediato ao trabalho e que qualquer usuário leia, baixe, copie, distribua, imprima, pesquise ou vincule aos textos completos dos artigos, rastreando-os para indexação, passá-los como dados para o software, ou usá-los para qualquer outra finalidade legal.